Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

ACON

Aclarion (ACON)

Aclarion Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ACON
FechaHoraFuenteTítuloSímboloCompañía
25/04/202408:14GlobeNewswire Inc.Aclarion’s Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back PainNASDAQ:ACONAclarion Inc
06/03/202415:09Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ACONAclarion Inc
04/03/202407:00GlobeNewswire Inc.Aclarion Announces Publication of Compelling Peer-Reviewed Data in International Journal of Spine Surgery Supporting Nociscan as a Gold Standard for Noninvasive Identification of Painful Lumbar DiscsNASDAQ:ACONAclarion Inc
27/02/202414:22GlobeNewswire Inc.Aclarion Announces Closing of $3.0 Million Public OfferingNASDAQ:ACONAclarion Inc
27/02/202413:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACONAclarion Inc
27/02/202409:46Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:ACONAclarion Inc
26/02/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ACONAclarion Inc
26/02/202408:15GlobeNewswire Inc.Aclarion Announces Pricing of $3.0 Million Public OfferingNASDAQ:ACONAclarion Inc
23/02/202410:46Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ACONAclarion Inc
05/02/202407:00GlobeNewswire Inc.Aclarion Announces Successful Financings; Plans to Launch CLARITY Trial and Provides Update on Next Steps of Alphatec Strategic PartnershipNASDAQ:ACONAclarion Inc
01/02/202416:16Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ACONAclarion Inc
22/01/202415:48Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:ACONAclarion Inc
22/01/202407:00GlobeNewswire Inc.Aclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MDNASDAQ:ACONAclarion Inc
17/01/202407:00GlobeNewswire Inc.Aclarion Announces Updated Product Release That Expands MRI Scanner Access for Nociscan SolutionNASDAQ:ACONAclarion Inc
08/01/202407:00GlobeNewswire Inc.Aclarion and ATEC Execute Strategic Partnership Agreement to Advance Commercialization of NociscanNASDAQ:ACONAclarion Inc
02/01/202411:00GlobeNewswire Inc.Aclarion Announces Reverse Stock SplitNASDAQ:ACONAclarion Inc
29/12/202305:30Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ACONAclarion Inc
27/11/202307:00GlobeNewswire Inc.Aclarion Announces Key Commercial Milestone With Completion of 1,000 Nociscan ExamsNASDAQ:ACONAclarion Inc
13/11/202305:00Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ACONAclarion Inc
08/11/202307:00GlobeNewswire Inc.Aclarion Announces Achievement of Goal to Enroll 10 Leading Spine Surgery Key Opinion Leaders (KOLs) to Support Nociscan AdoptionNASDAQ:ACONAclarion Inc
06/11/202307:00GlobeNewswire Inc.Aclarion Expands Immediate Nociscan Access Into New York City With Tenth Key Opinion Leader Surgeon Advisor Addition Roger Hartl, MDNASDAQ:ACONAclarion Inc
01/11/202315:15Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:ACONAclarion Inc
01/11/202307:00GlobeNewswire Inc.Aclarion Presents at the NIH HEAL Initiative Fall MeetingNASDAQ:ACONAclarion Inc
25/10/202307:30GlobeNewswire Inc.Aclarion Announces Signing of Commercial Agreement With Porter Hospital, an AdventHealth facility, to Bring Nociscan Technology to DenverNASDAQ:ACONAclarion Inc
24/10/202307:45GlobeNewswire Inc.Aclarion Announces Nociscan® Cost-Effectiveness Poster Presented at 45th Annual SMDM MeetingNASDAQ:ACONAclarion Inc
23/10/202306:00GlobeNewswire Inc.Aclarion Announces Signing Strategic Partnership Letter of Intent With ATEC to Advance Commercialization of NociscanNASDAQ:ACONAclarion Inc
02/10/202307:00GlobeNewswire Inc.Aclarion Provides Updated Investor Presentation and Corporate UpdateNASDAQ:ACONAclarion Inc
25/08/202315:10GlobeNewswire Inc.Aclarion, Inc. Announces Filing of Delayed 10-Q Quarterly ReportNASDAQ:ACONAclarion Inc
25/08/202312:04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ACONAclarion Inc
14/08/202315:27Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:ACONAclarion Inc
 Showing the most relevant articles for your search:NASDAQ:ACON